Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020092100 - SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SUBSTITUTED INDANE AND METHODS FOR THE PREPARATION AND USE THEREOF

Publication Number WO/2020/092100
Publication Date 07.05.2020
International Application No. PCT/US2019/057725
International Filing Date 23.10.2019
IPC
A61K 31/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
095Sulfur, selenium or tellurium compounds, e.g. thiols
10Sulfides; Sulfoxides; Sulfones
A61K 31/275 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
275Nitriles; Isonitriles
A61P 9/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
12Antihypertensives
Applicants
  • PELOTON THERAPEUTICS, INC. [US]/[US]
Inventors
  • LINDEMANN, Christopher
  • STENGEL, Peter J.
Agents
  • CLARK, David
Priority Data
62/752,68530.10.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SUBSTITUTED INDANE AND METHODS FOR THE PREPARATION AND USE THEREOF
(FR) DISPERSIONS SOLIDES ET COMPOSITIONS PHARMACEUTIQUES COMPRENANT UN INDANE SUBSTITUÉ ET LEURS PROCÉDÉS DE PRÉPARATION ET LEURS MÉTHODES D'UTILISATION
Abstract
(EN)
Provided herein are solid dispersions comprising a HIF-2α inhibitor, pharmaceutical compositions comprising the solid dispersions, and methods for treating HIF-2α-mediated diseases and conditions.
(FR)
L'invention concerne des dispersions solides comprenant un inhibiteur de HIF-2α, des compositions pharmaceutiques comprenant les dispersions solides, et des méthodes de traitement de maladies et d'affections médiées par le HIF-2α.
Latest bibliographic data on file with the International Bureau